HTA221 Market Access Challenges for Gene Therapies in Inherited Blood Disorders: A Retrospective Evaluation of HTA Outcomes for Sickle Cell Disease and Thalassemia
Abstract
Authors
R Dey
R Dey
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now